These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 9316212)

  • 1. Role of angiotensin II in diabetic nephropathy.
    Kennefick TM; Anderson S
    Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of local and systemic angiotensin in diabetic renal disease.
    Anderson S
    Kidney Int Suppl; 1997 Dec; 63():S107-10. PubMed ID: 9407435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat.
    Anderson S
    Miner Electrolyte Metab; 1998; 24(6):406-11. PubMed ID: 9930380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
    Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
    Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB; Coffman TM
    Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of a local renin angiotensin system in podocytes by glucose.
    Durvasula RV; Shankland SJ
    Am J Physiol Renal Physiol; 2008 Apr; 294(4):F830-9. PubMed ID: 18216149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visfatin stimulates a cellular renin-angiotensin system in cultured rat mesangial cells.
    Huang Q; Guo Y; Zeng H; Xie W; Yan H; Ding H
    Endocr Res; 2011; 36(3):93-100. PubMed ID: 21314328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The renin angiotensin system in diabetes mellitus. A physiological and therapeutic study.
    Björck S
    Scand J Urol Nephrol Suppl; 1990; 126():1-51. PubMed ID: 2194280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glomerular renin angiotensin system in streptozotocin diabetic and Zucker diabetic fatty rats.
    Leehey DJ; Singh AK; Bast JP; Sethupathi P; Singh R
    Transl Res; 2008 Apr; 151(4):208-16. PubMed ID: 18355768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
    Singh R; Singh AK; Leehey DJ
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1183-90. PubMed ID: 15701818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
    García VM; Monasterolo LA; Elías MM
    Acta Diabetol; 2003 Sep; 40(3):130-6. PubMed ID: 14605969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of renal renin-angiotensin system in mouse diabetic nephropathy.
    Tamura J; Konno A; Hashimoto Y; Kon Y
    Jpn J Vet Res; 2005 Aug; 53(1-2):13-26. PubMed ID: 16190318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum angiotensin-converting enzyme activity and plasma angiotensin II levels during pregnancy and postpartum in the diabetic rat.
    van Dijk DJ; Boner G; Giler S; Erman A
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):193-8. PubMed ID: 11881122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II and its receptors in the diabetic kidney.
    Burns KD
    Am J Kidney Dis; 2000 Sep; 36(3):449-67. PubMed ID: 10977776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review.
    Ibrahim HN; Rosenberg ME; Hostetter TH
    Semin Nephrol; 1997 Sep; 17(5):431-40. PubMed ID: 9316211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors in diabetes: effect on the kidney and on blood pressure.
    Björck S; Aurell M
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S59-63. PubMed ID: 16989067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.